Genetics of t(11;14)(q13;q32)-negative MCL

被引：0
|
作者：
Wlodarska, I.
Vanhentenrijk, V.
Pospisilova, H.
Van Roosbroeck, K.
Stul, M.
Francesca, M.
Dierickx, D.
Verhoef, G.
Vandenberghe, P.
Dewolf-Peeters, C.
机构：
[1] Univ Leuven, Dept Pathol, Louvain, Belgium
[2] Univ Leuven, Dept Hematol, Louvain, Belgium
来源：
ACTA CLINICA BELGICA | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [41] Myeloma (MM) and the t(11;14)(q13;q32); Increasing evidence for a biologically distinct subset of patients.
    Fonseca, R
    Harrington, D
    Oken, MM
    Hoyer, JD
    Dewald, GW
    Bailey, RJ
    Van Wier, SA
    Henderson, KJ
    Kay, NE
    van Ness, B
    Blood, EA
    Greipp, PR
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [42] Cytogenetics in multiple myeloma:: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant
    Laï, JL
    Michaux, L
    Dastugue, N
    Vasseur, F
    Daudignon, A
    Facon, T
    Bauters, F
    Zandecki, M
    CANCER GENETICS AND CYTOGENETICS, 1998, 104 (02) : 133 - 138
  • [43] GENE REARRANGEMENT AND OVEREXPRESSION OF PRAD1 IN LYMPHOID MALIGNANCY WITH T(11/14)(Q13/Q32) TRANSLOCATION
    SETO, M
    YAMAMOTO, K
    IIDA, S
    AKAO, Y
    UTSUMI, KR
    KUBONISHI, I
    MIYOSHI, I
    OHTSUKI, T
    YAWATA, Y
    NAMBA, M
    MOTOKURA, T
    ARNOLD, A
    TAKAHASHI, T
    UEDA, R
    ONCOGENE, 1992, 7 (07) : 1401 - 1406
  • [44] Cytogenetics in multiple myeloma: A multicentre study of 24 patients with t(11;14) (q13;q32) or variant.
    Lai, JL
    Michaux, L
    Dastugue, N
    Daudignon, A
    Vasseur, F
    Zandecki, M
    Bauters, F
    Facon, T
    BLOOD, 1996, 88 (10) : 1542 - 1542
  • [45] Value of interphase FISH for the diagnosis of t(11;14)(q13;q32) on skin lesions of mantle cell lymphoma
    Dubus, P
    Young, P
    Beylot-Barry, M
    Belaud-Rotureau, MA
    Courville, P
    Vergier, B
    Parrens, M
    Lenormand, B
    Joly, P
    Merlio, JP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (06) : 832 - 841
  • [46] Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and-17p13 in myeloma patients treated with high-dose therapy
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Greipp, PR
    Litzow, MR
    Henderson, KJ
    Van Wier, SA
    Ahmann, GJ
    Fonseca, R
    BLOOD, 2005, 106 (08) : 2837 - 2840
  • [47] BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders
    Michaux, L
    Mecucci, C
    Stul, M
    Wlodarska, I
    Hernandez, JM
    Meeus, P
    Michaux, JL
    Scheiff, JM
    Noel, H
    Louwagie, A
    Criel, A
    Boogaerts, M
    VanOrshoven, A
    Cassiman, JJ
    VandenBerghe, H
    GENES CHROMOSOMES & CANCER, 1996, 15 (01): : 38 - 47
  • [48] MOLECULAR MAPPING OF THE CHROMOSOME-II BREAKPOINT OF T(11 17)(Q13 Q21) IN A T(11 14)(Q13 Q32)-POSITIVE-B NON-HODGKINS-LYMPHOMA
    WLODARSKA, I
    SCHOENMAKERS, E
    KAS, K
    MERREGAERT, J
    LEMAHIEU, V
    WEIER, U
    VANDENBERGHE, H
    VANDEVEN, WJM
    GENES CHROMOSOMES & CANCER, 1993, 8 (04): : 224 - 229
  • [49] Interphase FISH analysis on histologic sections of fixed tissues for t(11;14) (q13;q32) detection in mantle cell lymphoma and t(8;14)(q24;q32) in Burkitt's lymphoma
    Belaud-Rotureau, MA
    Parrens, M
    Dubus, P
    Turmo, M
    Lacroute, G
    Taine, L
    Vago, P
    de Mascarel, A
    Merlio, JP
    ANNALES DE PATHOLOGIE, 2002, 22 (02) : 145 - 149
  • [50] Clinicopathologic Analysis of the Impact of CD23 Expression in Plasma Cell Myeloma with t(11;14)(q13;q32)
    Buonaccorsi, J. N.
    Kroft, S. H.
    Harrington, A.
    Van Tuinen, P.
    Olteanu, H.
    LABORATORY INVESTIGATION, 2011, 91 : 288A - 288A
12345